Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison With Other GHRH Analogs: Half-Life Perspective

Sermorelin (1-29 NH2) ~2-3 min (rat) None Modified GRF 1-29 (CJC-1295 no DAC) ~30 min Amino acid substitutions CJC-1295 with DAC ~6-8 days Albumin binding via DAC Tesamorelin (1-40) ~30-40 min Extended C-terminus + modifications Native GHRH (1-44) ~2-3 min Non

This comparison does not assign a generated winner or score.

  • Sermorelin (1-29 NH2)
  • ~2-3 min (rat)
  • None
  • Modified GRF 1-29 (CJC-1295 no DAC)
  • ~30 min
  • Amino acid substitutions
  • CJC-1295 with DAC
  • ~6-8 days
  • Albumin binding via DAC
  • Tesamorelin (1-40)
  • ~30-40 min
  • Extended C-terminus + modifications
  • Native GHRH (1-44)
  • ~2-3 min
  • None (also DPP-IV substrate)
  • Table 3: Plasma half-life comparison across GHRH analogs in preclinical models.
  • For Tesamorelin vs. Sermorelin comparison, see our dedicated comparison article.
More references

Related material

Comparison

Route Comparison Summary

Intravenous (IV) 100% Immediate PK studies, acute GH response studies Subcutaneous (SC) ~40-70% 5-10 minutes Standard animal model studies Intranasal Low Variable Delivery route c…

View details →